FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Midfield Industries IPO and Parabolic Drugs IPO.
Midfield Industries IPO is a Mainline Book Built Issue IPO proposed to list at BSE while Parabolic Drugs IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Midfield Industries IPO | Parabolic Drugs IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE | BSE, NSE |
Lead Managers | Atherstone Capital Markets Limited | ICICI Securities Limited Spa Capital Advisors Ltd |
Registrar | Bigshare Services Pvt Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Midfield Industries IPO is up to ₹59.85 Cr whereas the issue size of the Parabolic Drugs IPO is up to ₹200.00 Cr. The final issue price of Midfield Industries IPO is ₹133.00 per share and of Parabolic Drugs IPO is ₹75.00 per share.
Midfield Industries IPO | Parabolic Drugs IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹126.00 per share | ₹75.00 per share |
Issue Price (Upper) | ₹133.00 per share | ₹85.00 per share |
Issue Price (Final) | ₹133.00 per share | ₹75.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 50 shares | 80 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 45,00,000 shares | 2,66,66,667 shares |
Issue Size Total (Amount) | up to ₹59.85 Cr | up to ₹200.00 Cr |
Midfield Industries IPO opens on Jul 19, 2010, while Parabolic Drugs IPO opens on Jun 14, 2010. The closing date of Midfield Industries IPO and Parabolic Drugs IPO is Jul 21, 2010, and Jun 17, 2010, respectively.
Midfield Industries IPO | Parabolic Drugs IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jul 19, 2010 | Jun 14, 2010 |
Issue Close | Jul 21, 2010 | Jun 17, 2010 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Midfield Industries IPO P/E ratio is , as compared to Parabolic Drugs IPO P/E ratio of .
Midfield Industries IPO | Parabolic Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 79.76% | 63.2% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 51.77% | 46.5% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 6.21%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 24.16%% | 19.96%% |
In the Midfield Industries IPO retail investors (RII) are offered 15,75,000 shares while in Parabolic Drugs IPO retail investors are offered 15,75,000 shares. Qualified institutional buyers (QIB) are offered 22,50,000 shares in Midfield Industries IPO and 1,30,83,333 shares in Parabolic Drugs IPO.
Midfield Industries IPO | Parabolic Drugs IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 22,50,000 shares | 1,30,83,333 shares |
NII | 6,75,000 shares | 39,25,000 shares |
RII | 15,75,000 shares | 91,58,334 shares |
Employee | 5,00,000 shares | |
Others | ||
Total | 45,00,000 shares | 2,66,66,667 shares |
Midfield Industries IPO subscribed 12.92x in total, whereas Parabolic Drugs IPO subscribed 1.04x.
Midfield Industries IPO | Parabolic Drugs IPO | |
---|---|---|
QIB (times) | 1.86x | 1.48x |
NII (times) | 48.41x | 1.20x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 13.51x | 0.40x |
Employee (times) | 0.11x | |
Other (times) | ||
Total (times) | 12.92x | 1.04x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|